Banque Cantonale Vaudoise Decreases Holdings in HCA Healthcare, Inc. $HCA

Banque Cantonale Vaudoise decreased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 36.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,447 shares of the company’s stock after selling 3,176 shares during the period. Banque Cantonale Vaudoise’s holdings in HCA Healthcare were worth $2,543,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Holos Integrated Wealth LLC purchased a new position in shares of HCA Healthcare in the fourth quarter worth $29,000. Palisade Asset Management LLC purchased a new position in shares of HCA Healthcare in the third quarter worth $26,000. Ares Financial Consulting LLC purchased a new position in shares of HCA Healthcare in the fourth quarter worth $31,000. Aventura Private Wealth LLC purchased a new position in shares of HCA Healthcare in the fourth quarter worth $34,000. Finally, Key Capital Management INC purchased a new position in shares of HCA Healthcare in the fourth quarter worth $35,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on HCA. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of HCA Healthcare in a report on Wednesday, March 4th. Wells Fargo & Company reduced their target price on shares of HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating for the company in a report on Monday, April 27th. Oppenheimer reduced their target price on shares of HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating for the company in a report on Monday, April 27th. Wall Street Zen cut shares of HCA Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Finally, Leerink Partners reduced their target price on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a report on Monday, April 27th. Sixteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $515.77.

HCA Healthcare News Roundup

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA Healthcare received a consensus “Moderate Buy” rating from brokerages, suggesting Wall Street still sees upside despite recent volatility.
• Positive Sentiment: HCA Healthcare said colleagues volunteered more than 41,800 hours during its annual Days of Service initiative, reinforcing the company’s community and brand reputation. HCA Healthcare Colleagues Volunteer More Than 41,800 Hours During Annual Days of Service Initiative
• Positive Sentiment: At the RBC Capital Markets Global Healthcare Conference, HCA Healthcare’s presentation likely helped keep investors focused on the company’s strategy and fundamentals. HCA Healthcare, Inc. (HCA) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
• Neutral Sentiment: Local articles about HCA Florida Lawnwood and other HCA facilities recognizing trauma staff and first responders are largely reputational and unlikely to materially affect near-term earnings. HCA Florida Lawnwood honors survivors, praises first responders and trauma staff HCA observes trauma awareness
• Neutral Sentiment: Reports that HCA hospitals are spending more than $10 million on employee pay raises signal ongoing labor-cost investment, but the market may view this as a cost headwind rather than a clear catalyst. Mission Hospital spends more than $10M on employee pay raises HCA hospital invests $10M to bump payroll
• Negative Sentiment: JPMorgan lowered its price target on HCA Healthcare from $535 to $490 and kept a neutral rating, which may be weighing on investor sentiment. JPMorgan adjusts price target on HCA Healthcare to 490 from 535, maintains neutral rating
• Negative Sentiment: The lower price target, combined with the stock trading well below recent highs, reinforces concerns that near-term upside may be limited.

HCA Healthcare Stock Performance

HCA opened at $397.08 on Thursday. HCA Healthcare, Inc. has a fifty-two week low of $330.00 and a fifty-two week high of $556.52. The company has a fifty day moving average of $470.92 and a two-hundred day moving average of $484.72. The stock has a market capitalization of $88.09 billion, a price-to-earnings ratio of 13.65, a PEG ratio of 1.28 and a beta of 1.18.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm had revenue of $19.11 billion during the quarter, compared to analysts’ expectations of $19.09 billion. During the same period in the previous year, the firm posted $6.45 EPS. The firm’s quarterly revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities research analysts forecast that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be given a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is 10.73%.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.